Iron intake variation however, is not likely to have affected the main finding of this study which was that obesity-related inflammation in the absence of comorbidity did not elicit significant hepcidin-mediated iron disruptions. The gene discussed is HAMP; the disease is obesity due to melanocortin 4 receptor deficiency.